ResearcherUniversity of California, San FranciscoActive in the last 2 years

Phoebe N. Miller

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3938-3606; OpenAlex author ID A5054991024. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 10

Papers, trials and grants by year

2024: 2 papers

Papers 2

Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer. Co-author DOI 10.1245/s10434-024-15579-0 ↗
ASO Author Reflections: Total Neoadjuvant Therapy with Chemotherapy Alone for Pancreatic Cancer? Co-author DOI 10.1245/s10434-024-15660-8 ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Eric K. Nakakura · 2 shared papers, 2024 · strength 0.63
- Paper ASO Author Reflections: Total Neoadjuvant Therapy with Chemotherapy Alone for Pancreatic Cancer? DOI 10.1245/s10434-024-15660-8 ↗
- Paper Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancre… DOI 10.1245/s10434-024-15579-0 ↗
Andrew H. Ko · 1 shared paper, 2024 · strength 0.18
- Paper Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancre… DOI 10.1245/s10434-024-15579-0 ↗
Mohamed A. Adam · 1 shared paper, 2024 · strength 0.18
- Paper Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancre… DOI 10.1245/s10434-024-15579-0 ↗
Adnan A. Alseidi · 1 shared paper, 2024 · strength 0.18
- Paper Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancre… DOI 10.1245/s10434-024-15579-0 ↗
Sunhee S. Kim · 1 shared paper, 2024 · strength 0.18
- Paper Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancre… DOI 10.1245/s10434-024-15579-0 ↗
Ajay V. Maker · 1 shared paper, 2024 · strength 0.18
- Paper Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancre… DOI 10.1245/s10434-024-15579-0 ↗
Jane Wang · 1 shared paper, 2024 · strength 0.18
- Paper Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancre… DOI 10.1245/s10434-024-15579-0 ↗
Grace Kim · 1 shared paper, 2024 · strength 0.18
- Paper Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancre… DOI 10.1245/s10434-024-15579-0 ↗
Kimberly Saunders Kirkwood · 1 shared paper, 2024 · strength 0.18
- Paper Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancre… DOI 10.1245/s10434-024-15579-0 ↗
Margaret A. Tempero · 1 shared paper, 2024 · strength 0.18
- Paper Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancre… DOI 10.1245/s10434-024-15579-0 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.